Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study

被引：1
|
作者：
Chiorean, E. G.
Sweeney, C. J.
Verschraegen, C. F.
Lee, F. C.
Jones, S. F.
Rabinowitz, I.
Tye, L.
Bello, A.
Chao, R.
Burris, H. A., III
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3562
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I safety and pharmacokinetic (PK) study of SU014813 (S) in combination with docetaxel (D) in patients (pts) with solid tumors (STs)
    Schoffski, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors
    Bhuvaneswari Ramaswamy
    Mitch A. Phelps
    Robert Baiocchi
    Tanios Bekaii-Saab
    Wenjun Ni
    Ju-Ping Lai
    Anna Wolfson
    Mark E. Lustberg
    Lai Wei
    Deidre Wilkins
    Angela Campbell
    Daria Arbogast
    Austin Doyle
    John C. Byrd
    Michael R. Grever
    Manisha H. Shah
    Investigational New Drugs, 2012, 30 : 629 - 638
  • [33] A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors
    Ramaswamy, Bhuvaneswari
    Phelps, Mitch A.
    Baiocchi, Robert
    Bekaii-Saab, Tanios
    Ni, Wenjun
    Lai, Ju-Ping
    Wolfson, Anna
    Lustberg, Mark E.
    Wei, Lai
    Wilkins, Deidre
    Campbell, Angela
    Arbogast, Daria
    Doyle, Austin
    Byrd, John C.
    Grever, Michael R.
    Shah, Manisha H.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 629 - 638
  • [34] Sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors: a phase I dose-escalation and pharmacokinetic (PK) study
    Traynor, A.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    VerMeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Robert, F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 110 - 110
  • [35] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.
    Fetterly, Gerald J.
    Pitzonka, Laura
    Zhao, Yujle
    Dy, Grace K.
    Iyer, Renuka V.
    Taubes, Susan
    Perez, Jose Ricardo
    Culver, Kenneth W.
    Wilton, John
    Monglardo, Krystin
    Tan, Wei
    Brady, William E.
    Whitworth, Amy
    Adjei, Alox A.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study (vol 31, pg 677, 2013)
    Asahina, Hajime
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Tamura, Yosuke
    Honda, Kazunori
    Seki, Yoshitaka
    Tanabe, Yuko
    Shimada, Hitoshi
    Shi, Xiaojin
    Tamura, Tomohide
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 798 - 798
  • [38] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Poveda, Andres
    Oaknin, Ana
    Romero, Ignacio
    Guerrero-Zotano, Angel
    Farinas-Madrid, Lorena
    Rodriguez-Freixinos, Victor
    Mallol, Pedro
    Lopez-Reig, Raquel
    Antonio Lopez-Guerrero, Jose
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Andres Poveda
    Ana Oaknin
    Ignacio Romero
    Angel Guerrero-Zotano
    Lorena Fariñas-Madrid
    Victor Rodriguez-Freixinos
    Pedro Mallol
    Raquel Lopez-Reig
    Jose Antonio Lopez-Guerrero
    Scientific Reports, 11
  • [40] Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Weiss, J
    Ferrier, A
    Vukovic, V
    Weitman, S
    Richards, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 223S - 223S
12345